You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

qva149

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in Sheffield, Bradford, Manchester (QVA149, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • Placebo
  • Sheffield, South Yorkshire, United Kingdom
  • +2 more
Dec 9, 2020

COPD, COPD Trial in Hannover (QVA149, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • QVA149
  • Placebo
  • Hannover, Germany
    Novartis Investigative Site
Dec 10, 2018

COPD Trial in Denmark, Norway, Sweden (QVA149, QVA149 Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • QVA149 Placebo
  • Aarhus, Denmark
  • +4 more
Nov 10, 2017

COPD (COPD) Trial in Worldwide (QVA149, Tiotropium, Salmeterol/fluticasone)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +166 more
Jan 25, 2019

COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • +3 more
  • Anaheim, California
  • +52 more
Mar 2, 2018

COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • +3 more
  • Andalusia, Alabama
  • +57 more
Nov 30, 2017

COPD, COPD Trial in Germany (QVA149, Tiotropium)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • COPD
  • Ibbenbüren, Rheinland Pfalz, Germany
  • +17 more
Mar 14, 2017

COPD Trial in Germany (QVA149, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • Placebo
  • Koblenz, NRW, Germany
  • +29 more
Mar 7, 2016

COPD (COPD) Trial in Worldwide (QVA149, QAB149, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • +2 more
  • Vestavia, Alabama
  • +85 more
Feb 29, 2016

COPD (COPD) Trial in Worldwide (QVA149, Tiotropium, )

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +115 more
May 9, 2016

COPD (COPD) Trial in Worldwide (QVA149, Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS)
  • Caba, Buenos Aires, Argentina
  • +495 more
May 5, 2016

COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • +3 more
  • Birmingham, Alabama
  • +142 more
Mar 2, 2016

COPD Trial in Worldwide (QVA149, Fluticasone/salmeterol, Placebo to QVA149)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • +3 more
  • Caba, Buenos Aires, Argentina
  • +55 more
Mar 13, 2015

COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • +3 more
  • Huntsville, Alabama
  • +94 more
Jul 13, 2015

COPD Trial in Worldwide (QVA149, NVA237, QAB149)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • +3 more
  • Feldbach, Austria
  • +25 more
Jan 16, 2014

COPD (COPD) Trial in Germany (QVA149, Placebo to tiotropium, Placebo to formoterol)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • QVA149
  • +5 more
  • Koblenz, NRW, Germany
  • +142 more
May 19, 2014

COPD Trial in Worldwide (QVA149, Tiotropium, Placebo to QVA149)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • +4 more
  • Bruxelles, Belgium
  • +42 more
Nov 5, 2013

COPD (COPD) Trial in Japan (QVA149, Tiotropium)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Anjo, Aichi, Japan
  • +34 more
Dec 3, 2013

COPD Trial in Austria, Germany (QVA149, fluticasone/salmeterol)

Withdrawn
  • Chronic Obstructive Pulmonary Disease
  • Feldkirch, Austria
  • +28 more
Nov 8, 2013

COPD Trial in Worldwide (QVA149, fluticasone/salmeterol)

Withdrawn
  • Chronic Obstructive Pulmonary Disease
  • San Miguel de Tucuman, Tucuman, Argentina
  • +30 more
Nov 8, 2013

COPD Trial in Worldwide (QVA149, NVA237, tiotropium)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • +3 more
  • Birmingham, Alabama
  • +344 more
Oct 29, 2013

COPD Trial in Worldwide (QVA149, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • QVA149
  • Placebo
  • Toronto, Ontario, Canada
  • +52 more
Jan 28, 2013